Patient Prefer Adher
-
Patient Prefer Adher · Jan 2020
A Qualitative Study of Barriers and Facilitators to Adherence to Secondary Prevention Medications Among French Patients Suffering from Stroke and Transient Ischemic Attack.
Secondary prevention medications (SPM) reduce the risk of ischemic stroke (IS) and transient ischemic attack (TIA) recurrence. However, approximately one-third of patients are estimated to be non-adherent. This qualitative study aimed to explore barriers and facilitators to adherence to SPM after IS or TIA. ⋯ Information on SPM is inadequate in terms of quantity and timing both during the acute IS/TIA period and over the long term. Providing more tailor-made information at an opportune moment, in particular by promoting discussion with their general practitioner (GP) throughout the course of illness and recovery, is essential to ensure that patients are not left alone in the decision-making process regarding adherence to SPM.
-
Patient Prefer Adher · Jan 2020
Oral Health-Related Quality of Life of Saudi Young Adults with Vertical Discrepancies in Occlusion.
Malocclusion is one of the most common oral health problems that affects quality of life. It is important to understand how different types of malocclusion can affect the oral health-related quality of life (OHRQoL). Vertical discrepancy in occlusion is highly prevalent, yet there are no studies evaluating its impact on OHRQoL in the Saudi population. Therefore, in this study, we aim to investigate the impact of vertical discrepancy in occlusion on patients' OHRQoL. ⋯ Vertical discrepancy in occlusion has a negative impact on OHRQoL and its domains in both genders. The negative impact is highlighted in the psychological disability, psychological discomfort, physical pain, and functional limitation domains.
-
Patient Prefer Adher · Jan 2020
Assessing Preferences for Rare Disease Treatment: Qualitative Development of the Paroxysmal Nocturnal Hemoglobinuria Patient Preference Questionnaire (PNH-PPQ©).
To develop a patient preference questionnaire (PPQ) assessing eculizumab and ravulizumab treatment for paroxysmal nocturnal hemoglobinuria (PNH). ⋯ The PNH-PPQ provides a patient-centered approach for evaluating preferences for the treatment of PNH. The PNH-PPQ has subsequently assessed patient preference in the clinical trial sub-study ALXN1210-PNH-302s.
-
Patient Prefer Adher · Jan 2020
Defining Criteria for Guiding Cancer Patients to Find a Reputable Complementary Medicine Provider: Results of a Literature Review and a Consensus Procedure.
Even in cases of positive evidence for complementary medicine (CM) therapies, it is still difficult for cancer patients to identify reputable providers. The aim of this study was to develop and evaluate a criteria list to provide guidance to cancer patients seeking a reputable CM provider. ⋯ Health professionals and cancer information services might find the criteria list helpful when aiming to strengthen patients' awareness of quality-related factors associated with CM providers. The criteria developed might be helpful when standards are established for quality assurance in CM in oncology.
-
Patient Prefer Adher · Jan 2020
Correlation Between Patients' Medication Adherence and Their Psychological Contract with Hospital Pharmacists.
To investigate the correlation between patients' medication adherence and their psychological contract with hospital pharmacists under the background of the pharmacist-patient relationship, providing a reference for improving the pharmacist-patient relationship and the patients' medication adherence based on the patients' psychological contract with the hospital pharmacists. ⋯ Outpatients' psychological contract with the pharmacists is positively correlated with their medication adherence. Maintaining the patients' psychological contract with the pharmacists may be an effective way to improve medication adherence.